Skip to content
healthcare.dev

ZITUVIMET XR

NDC 70771-1880, sitagliptin and metformin hydrochloride, tablet, film coated, extended release, from Zydus Lifesciences Limited.

Product NDC
70771-1880
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216778
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1880 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SITAGLIPTIN50 mg/1
  • METFORMIN HYDROCHLORIDE1000 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

Package NDCNDC-11Package
70771-1880-67077118800660 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1880-6)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4bade493-499e-434a-97a0-26ca68917623

Use it

Look up 70771-1880 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1880 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1880. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.